In this presentation I have tried to explain the types, etiology, pathophysiology of respiratory tract infections such as bronchitis, pnemonia, otitis media, sinusitis, pharyngitis, and their treatment
Anti Tubercular Drugs - Mechanism of Action and Adverse effects Thomas Kurian
A brief outline of the mechanism of action and adverse effects of anti tubercular drugs
Only First line and second line drugs are dealt with.First line drugs may be useful for MBBS students and the rest is directed for postgraduate students.
Hope you find it useful.
This PDF deals with important guidelines, with respect to usage of antibiotics. This PDF outlines the important strategies involved while using antibiotics, and important factors involving antibiotic selection.
Anti Tubercular Drugs - Mechanism of Action and Adverse effects Thomas Kurian
A brief outline of the mechanism of action and adverse effects of anti tubercular drugs
Only First line and second line drugs are dealt with.First line drugs may be useful for MBBS students and the rest is directed for postgraduate students.
Hope you find it useful.
This PDF deals with important guidelines, with respect to usage of antibiotics. This PDF outlines the important strategies involved while using antibiotics, and important factors involving antibiotic selection.
Child health nursing case presentation and case study topic is pneumonia in children pediatric
Health education in pneumonia
CHN pneumonia
Case presentation pneumonia
Case study pneumonia
Pneumonia is an infection that inflames the air sacs in one or both lungs. The air sacs may fill with fluid or pus (purulent material), causing cough with phlegm or pus, fever, chills, and difficulty breathing. A variety of organisms, including bacteria, viruses and fungi, can cause pneumonia.
Pneumonia can range in seriousness from mild to life-threatening. It is most serious for infants and young children, people older than age 65, and people with health problems or weakened immune systems.
An inflammatory process in lung parenchyma usually associated with a marked increase in interstitial and alveolar fluid
the topic covers the
definition, etiology, Pathophysiology, Clinical manifestation, Diagnostic Evaluation, Medical Management, Nursing Management & nursing diagnosis.
Through this SlideShare you can understand about Pneumonia..
How it occurr, what are the etiology, how many types are there , what is the medicine for this disease conditions, how to recover from this disease conditions and how to prevent all this things...
If it is helpful then please like and share others and help others to get knowledge about this disease conditions ( Pneumonia ).
Similar to Respiratory Tract Infections- A Pharmacotherapeutic Approach (20)
The Emerging Role of Pharmacists in Public Health.pptxDr. Ankit Gaur
The Emerging Role of Pharmacists in Public Health: Opportunities and Challenges
General system theory, steven's system model, Pharmacists in india, Disaster management and emergency care, rational use of medicine, RNTCP programme. National Aids Control Programme.
This presentation is about Stress and its impact on health. I have tried to cover everything related to it, stressors, coping mechanisms, tools, types etc.
Gastro esophageal Reflux Disease (GERD) and its managementDr. Ankit Gaur
In this presentation I have tried to explain in brief about gastro esophageal Reflux Disease (GERD), its etiology, risk factors, diagnosis, and its management via pharmacotherapy.
In this presentation I have tried to discuss in brief about obsessive compulsive disorder and its treatment both pharmacological and non pharmacological.
In this presentation I have tried to explain in brief about pain management, different types of pain, its diagnostic criteria, its physiology, and its treatment approaches both pharmacological and non pharmacological
In this presentation I have tried to explain in brief about the dosage adjustment in renal disorders, how to carry out this process and the important formulae which are used in it.
In this presentation i have tried to explain in brief about nomograms and their applications, the general approach to individualise doage regimen by using pharmacokinetic data
In this presentation I have tried to explain in detail about tablets, their different types, ingredients which are used to prepare them, and the procedure to prepare them as well. This presentation is very useful for pharmacy students.
In this presentation i have tried to explain in details about the Total Parenteral Nutrition (TPN) , what is it, who needs it, and how to prepare it and the necessary procedure with instructions. It is very useful for the individuals from Nutrition, Nursing, Pharmacists, and Medical background.
in this presentation i have tried to briefly discuss about diuretics (water pills), their classification, mechanism of action, pharmacokinetics and pharmacodynamics of these drugs
In this presentation i have tried to explain in brief about CPR, how and when it has to be done and the important things to be kept in mind while doing it. This ppt is very helpful for every individual who is looking for the info regarding CPR.
In this presentation i have tried to explain in detail about the nux vomica and khurchi bark. This presentation is useful for the individuals who are looking for information on this topic especially for those students who are studying Pharmacognosy.
In this presentation i have tried to explain in detail about the measurements of the outcomes which are used in epidemiology such as prevalence, incidence, fatality rate, crude death rate etc.
In this presentation i tried to explain in detail about cohort studies, their types, how to conduct them, their outcomes, and how to calculate sample size of these studies.
In this presentation i have tried to thoroughly discuss about the concept of Drug induced kidney disease or injury, the mechanism behind it, its classification and how to access it.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Respiratory Tract Infections- A Pharmacotherapeutic Approach
1. Respiratory tractRespiratory tract
infections and theirinfections and their
treatment (Atreatment (A
PharmacotherapeuticPharmacotherapeutic
Approach)Approach)
By: Dr. Ankit Gaur
Pharm.D, M.Sc, RPh
2. Upper respiratory tractUpper respiratory tract
nose, nasal cavity, sinuses,nose, nasal cavity, sinuses,
mouth, throatmouth, throat
Lower respiratory tractLower respiratory tract
Trachea, bronchi,Trachea, bronchi,
bronchioles, andbronchioles, and
alveoli in the lungsalveoli in the lungs
3. Lower respiratory tract infectionLower respiratory tract infection
BronchitisBronchitis
--Inflammatory conditions of bronchial tubesInflammatory conditions of bronchial tubes
Classified asClassified as
AcuteAcute -- occurs in all age,occurs in all age,manifested by cough and, occasionally, sputummanifested by cough and, occasionally, sputum
production that last for no more than 3 weeks.production that last for no more than 3 weeks.
ChronicChronic -- occurs mostly in infants,occurs mostly in infants,cough with sputum expectoration for atcough with sputum expectoration for at
least 3 months a year during a period of 2 consecutive yearsleast 3 months a year during a period of 2 consecutive years
4. EtiologyEtiology
Cold.Cold.
Damp climate.Damp climate.
Presence of high concentration of irritating substance.Presence of high concentration of irritating substance.
Influenza virusInfluenza virus
Common cold virusCommon cold virus
Mycoplasma pneumoniaesMycoplasma pneumoniaes
5. PathogensisPathogensis
infection of trachea & bronchiinfection of trachea & bronchi
edematous mucous membrane with increaseedematous mucous membrane with increase
in bronchial secretionin bronchial secretion
destruction of respiratory epitheliumdestruction of respiratory epithelium
impairs bronchial mucociliary function.impairs bronchial mucociliary function.
the air passages become clogged by debristhe air passages become clogged by debris
narrowing of airways and obstruction in breathingnarrowing of airways and obstruction in breathing
6. Clinical presentationClinical presentation
Acute bronchitisAcute bronchitis
Signs and symptomsSigns and symptoms
Cough persisting more than 5days ,purulent sputum ,malaise ,headacheCough persisting more than 5days ,purulent sputum ,malaise ,headache
Physical examinationPhysical examination
Rhonchi or coarses, moist, bilateral ralesRhonchi or coarses, moist, bilateral rales
Chest radiograph : normalChest radiograph : normal
Siprometry :large reduction of fev1Siprometry :large reduction of fev1
Bacterial culture.Bacterial culture.
Chronic bronchitisChronic bronchitis
Signs and symptomsSigns and symptoms
Smokers cough, dyspnea ,wheezing ,coughing productive of purulent sputumSmokers cough, dyspnea ,wheezing ,coughing productive of purulent sputum
7. Physical examinationPhysical examination
Clubbing of digits, mild wheezing normal vesicular breathing sounds areClubbing of digits, mild wheezing normal vesicular breathing sounds are
diminisheddiminished
Chest radiographChest radiograph
Observed as barrel chest ,depressed diaphragmObserved as barrel chest ,depressed diaphragm
SiprometrySiprometry:: decreased vital capacitydecreased vital capacity
prolonged expiratory flow.prolonged expiratory flow.
8. TreatmentTreatment
Acute bronchitisAcute bronchitis
aspirin : dose(650mg in adults or 10-15 mg/kg per dose in childrenaspirin : dose(650mg in adults or 10-15 mg/kg per dose in children
Ibuprofen : dose(200-800mg in adults 10mg/kg per dose in children)Ibuprofen : dose(200-800mg in adults 10mg/kg per dose in children)
To treat s. pneumonia – azithromycin.To treat s. pneumonia – azithromycin.
To treat from influneza virus – amantidine, rimantadine, neuraminidaseTo treat from influneza virus – amantidine, rimantadine, neuraminidase
inhibitor (zanamivir, oseltamivir effective against both A&B)inhibitor (zanamivir, oseltamivir effective against both A&B)
Chronic bronchitisChronic bronchitis
Short acting bronchodilators (albuterol aresol)Short acting bronchodilators (albuterol aresol)
Long term inhalation( ipratropium, tiotropium)Long term inhalation( ipratropium, tiotropium)
Antibiotic (ampicillin0.25-0.5,amoxicillin 0.5-0.8,ciprofloxacin,doxycycline)Antibiotic (ampicillin0.25-0.5,amoxicillin 0.5-0.8,ciprofloxacin,doxycycline)
Supplemental drugs (azithromycin, erythromycin)Supplemental drugs (azithromycin, erythromycin)
9. PneumoniaPneumonia
““pneumonia is defined as an Infection or inflammation of the lungpneumonia is defined as an Infection or inflammation of the lung
parenchyma caused most often by microbial pathogensparenchyma caused most often by microbial pathogens.”.”
EtiologyEtiology
BacteriaBacteria ::Streptococcus pneumoniaeStreptococcus pneumoniae ,, Klebsiella pneumoniae and HemophilusKlebsiella pneumoniae and Hemophilus
influenzaeinfluenzae..
Virus: Adenoviruses, rhinovirus, influenza virus (flu), respiratory syncytialVirus: Adenoviruses, rhinovirus, influenza virus (flu), respiratory syncytial
virus (RSV), and parainfluenza virusvirus (RSV), and parainfluenza virus
10. PathophysiologyPathophysiology
Aspiration of potential pathogens from oropharynxAspiration of potential pathogens from oropharynx
alveolar macrophages releases inflammatory mediators(IL1,TNF)alveolar macrophages releases inflammatory mediators(IL1,TNF)
Chemokines (IL8) stimulate release of neutrophils producing increasedChemokines (IL8) stimulate release of neutrophils producing increased
purulent secretionpurulent secretion
Inflammatory mediators lead to capillary leak leading to fluid filledInflammatory mediators lead to capillary leak leading to fluid filled
alveolialveoli
Decreases gas exchange within lung leading to hypoxiaDecreases gas exchange within lung leading to hypoxia
alveoli become solid because debris and fluid collectionalveoli become solid because debris and fluid collection
(conslidation)(conslidation)
11. Signs and symptomsSigns and symptoms
Abrupt onset of feverAbrupt onset of fever
ChillsChills
DyspneaDyspnea
Productive coughProductive cough
chest painchest pain
Rust colored sputum or hemoptysisRust colored sputum or hemoptysis
Physical examPhysical exam
Tachypnea and tachycardiaTachypnea and tachycardia
Diminshed breath sounds over affected areaDiminshed breath sounds over affected area
Inspiratory crackles during lung expansionInspiratory crackles during lung expansion
DiagnosisDiagnosis
Chest x_ray: dense lobar or segmental infilterateChest x_ray: dense lobar or segmental infilterate
SiprometrySiprometry
BronchoscopyBronchoscopy
Sputum testSputum test
Blood testBlood test
12. TreatmentTreatment
Bacterial pneumonia( s. pneumonia ):penicillin, ampicillin-clavulanateBacterial pneumonia( s. pneumonia ):penicillin, ampicillin-clavulanate
(Augmentin) and erythromycin.(Augmentin) and erythromycin.
Bacterial pneumonia (caused by the hemophilus influenza bacteria) :Bacterial pneumonia (caused by the hemophilus influenza bacteria) :
cefuroxime (Ceftin), ampicillin-clavulanate (Augmentin), ofloxacincefuroxime (Ceftin), ampicillin-clavulanate (Augmentin), ofloxacin
(Floxin), and trimethoprim-sulfamethoxazole (Bactrim and Septra).(Floxin), and trimethoprim-sulfamethoxazole (Bactrim and Septra).
Bacterial pneumonia (caused by legionella pneumophilia andBacterial pneumonia (caused by legionella pneumophilia and
staphylococcus aureus bacteria) are treated with antibiotics, such asstaphylococcus aureus bacteria) are treated with antibiotics, such as
erythromycin.erythromycin.
Mycoplasma pneumonia:Mycoplasma pneumonia: erythromycin, clarithromycin (Biaxin),erythromycin, clarithromycin (Biaxin),
tetracycline or azithromycin (Zithromax).tetracycline or azithromycin (Zithromax).
13. Upper respiratory tract infectionUpper respiratory tract infection
Otitis mediaOtitis media ::
““acute or chronic inflammation of the middle earacute or chronic inflammation of the middle ear espesp an acutean acute
inflammation esp. in infants or young children that is caused by a virus orinflammation esp. in infants or young children that is caused by a virus or
bacteriumbacterium
There are two typesThere are two types
Acute otitis mediaAcute otitis media ::usually of rapid onset and short duration. Acute otitisusually of rapid onset and short duration. Acute otitis
media is typically associated with fluid accumulation in the middle earmedia is typically associated with fluid accumulation in the middle ear
together with signs or symptoms of ear infection; a bulging eardrumtogether with signs or symptoms of ear infection; a bulging eardrum
usually accompanied by pain, or a perforated eardrum, often with drainageusually accompanied by pain, or a perforated eardrum, often with drainage
of purulent material (pus). fever can be present.of purulent material (pus). fever can be present.
Chronic otitis mediaChronic otitis media :: is a persistent inflammation of the middle ear,is a persistent inflammation of the middle ear,
typically for a minimum of a month. This is in distinction to an acute eartypically for a minimum of a month. This is in distinction to an acute ear
infection (acute otitis media) that usually lasts only several weeks.infection (acute otitis media) that usually lasts only several weeks.
14. EtiologyEtiology
Immune system: The immature immune systems of infants orImmune system: The immature immune systems of infants or
the impaired immune systems of patients with congenitalthe impaired immune systems of patients with congenital
immune deficiencies, HIV infection, or diabetes may beimmune deficiencies, HIV infection, or diabetes may be
involved in the development of OMinvolved in the development of OM
Genetic predispostionGenetic predispostion
Anatomic abnormailityAnatomic abnormaility
Bacterial pathogens like s.pneumonia,e.coliBacterial pathogens like s.pneumonia,e.coli
Virus:Virus: respiratory syncytial virusrespiratory syncytial virus (RSV), influenza viruses,(RSV), influenza viruses,
parainfluenza viruses, rhinovirus, and adenovirus.parainfluenza viruses, rhinovirus, and adenovirus.
enivronmental factors: smokersenivronmental factors: smokers
15. PathophysiolgyPathophysiolgy
In ET dysfunction (ETD), the mucosa at the pharyngeal end of the ET isIn ET dysfunction (ETD), the mucosa at the pharyngeal end of the ET is
part of the mucociliary system of the middle ear.part of the mucociliary system of the middle ear.
Interference with this mucosa by edema, tumor, or negative intratympanicInterference with this mucosa by edema, tumor, or negative intratympanic
pressure facilitates direct extension of infectious processes from thepressure facilitates direct extension of infectious processes from the
nasopharynx to the middle ear, causing OM.nasopharynx to the middle ear, causing OM.
Esophageal contents regurgitated into the nasopharynx and middle ear throughEsophageal contents regurgitated into the nasopharynx and middle ear through
the ET can create a direct mechanical disturbance of the middle ear mucosathe ET can create a direct mechanical disturbance of the middle ear mucosa
and cause middle ear inflammationand cause middle ear inflammation..
16. Signs and symptomsSigns and symptoms
Otalgia:Otalgia:
OtorrheaOtorrhea
Hearing lossHearing loss
FeverFever
Lethargy and vomittingLethargy and vomitting
DiagnosisDiagnosis
FeverFever
OtorrheaOtorrhea
Examination of tympanicExamination of tympanic
membrane by otoscopymembrane by otoscopy
18. SinusitisSinusitis
““Sinusitis is inflammation of the sinuses, which are air-Sinusitis is inflammation of the sinuses, which are air-
filled cavities in the skullfilled cavities in the skull ““
Sinusitis can be divided into the following categoriesSinusitis can be divided into the following categories::
– Acute sinusitis:Acute sinusitis: defined as symptoms of less than 4 weeks’ durationdefined as symptoms of less than 4 weeks’ duration
– Subacute sinusitis:Subacute sinusitis: defined as symptoms of 4 to 8 weeks’ duration;defined as symptoms of 4 to 8 weeks’ duration;
– Chronic sinusitis:Chronic sinusitis: defined as symptoms lasting longer than 8 weeksdefined as symptoms lasting longer than 8 weeks
– Recurrent acute sinusitis:Recurrent acute sinusitis: often defined as three or more episodes peroften defined as three or more episodes per
year, with each episode lasting less than 2 weeks.year, with each episode lasting less than 2 weeks.
19. EtiologyEtiology
Conditions that Predispose to SinusitisConditions that Predispose to Sinusitis
Allergic rhinitisAllergic rhinitis
Nonallergic rhinitisNonallergic rhinitis
Anatomic factors:Anatomic factors:
– Septal deviationsSeptal deviations
– Adenoid hypertrophyAdenoid hypertrophy
Hormonal conditions (e.g., progesterone-induced congestionHormonal conditions (e.g., progesterone-induced congestion
of pregnancy, rhinitis of hypothyroidism)of pregnancy, rhinitis of hypothyroidism)
Gastroesophageal refluxGastroesophageal reflux
Acquired immune deficiency:Acquired immune deficiency:
Human immunodeficiency virusHuman immunodeficiency virus
TransplantationTransplantation
ChemotherapyChemotherapy
Cystic fibrosisCystic fibrosis
20. PathophysiologyPathophysiology
viral infection can lead to inflammationviral infection can lead to inflammation
inflammation lead to causing sinus ostial blockageinflammation lead to causing sinus ostial blockage
anterior ethmoid, frontal, and maxillary sinuses drain into the middleanterior ethmoid, frontal, and maxillary sinuses drain into the middle
meatus, creating an anatomic area known as themeatus, creating an anatomic area known as the ostiomeatal complexostiomeatal complex
nasal mucosa responds to the virus by producing mucus and recruitingnasal mucosa responds to the virus by producing mucus and recruiting
mediators of inflammation, such as white blood cells, to the lining of themediators of inflammation, such as white blood cells, to the lining of the
nose, which cause congestion and swelling of the nasal passages.nose, which cause congestion and swelling of the nasal passages.
The resultant sinus cavity hypoxia and mucus retention cause the cilia toThe resultant sinus cavity hypoxia and mucus retention cause the cilia to
function less efficiently, creating an environment for bacterial growth.function less efficiently, creating an environment for bacterial growth.
21. Signs and symptomsSigns and symptoms
– Facial pain or pressureFacial pain or pressure
– Facial congestion or fullnessFacial congestion or fullness
– Nasal obstruction or blockageNasal obstruction or blockage
– Nasal discharge, purulence, postnasal dripNasal discharge, purulence, postnasal drip
– HeadacheHeadache
– FeverFever
– FatigueFatigue
– Dental painDental pain
– CoughCough
– Ear pain, pressure, fullnessEar pain, pressure, fullness
DiagnosisDiagnosis
Radiographic EvaluationRadiographic Evaluation
UltrasonographyUltrasonography
Nasal smearNasal smear
22. TreatmentTreatment
– Amoxicillin or trimethoprim/sulfamethoxazole(320-1600mg) every 12Amoxicillin or trimethoprim/sulfamethoxazole(320-1600mg) every 12thth
hourhour
– Amoxicillin –clavulanate-500mg-1g every 8Amoxicillin –clavulanate-500mg-1g every 8thth
hourhour
– Clarithromycin-250-500mg every 12 hrClarithromycin-250-500mg every 12 hr
– Azithromycin -500mg every 4Azithromycin -500mg every 4thth
hourhour
– Nasal decongestants (pseudoephidrine)-30-120mg 4-6 hrsNasal decongestants (pseudoephidrine)-30-120mg 4-6 hrs
PharyngitisPharyngitis
““Inflammation of pharynx and surrounding lymphoid tissue “Inflammation of pharynx and surrounding lymphoid tissue “
EtiologyEtiology
virus-rhinovirus ,coronavirusvirus-rhinovirus ,coronavirus
Bacteria-streptococcus pyogensBacteria-streptococcus pyogens
smokingsmoking
23. PathophysiologyPathophysiology
bacteria or viruses may directly invade the pharyngeal mucosa, causing abacteria or viruses may directly invade the pharyngeal mucosa, causing a
local inflammatory response.local inflammatory response.
Other viruses, such as rhinovirus and coronavirus, can cause irritation ofOther viruses, such as rhinovirus and coronavirus, can cause irritation of
pharyngeal mucosa secondary to nasal secretions.pharyngeal mucosa secondary to nasal secretions.
Streptococcal infections are characterized by local invasion and release ofStreptococcal infections are characterized by local invasion and release of
extracellular toxins and proteases.extracellular toxins and proteases.
Signs and symptomsSigns and symptoms
Sore throatSore throat
Pain on swallowingPain on swallowing
FeverFever
Enlarged lymph nodesEnlarged lymph nodes
Red swollen uvulaRed swollen uvula
24. DiagnosisDiagnosis
– Thorat swabThorat swab
– CultureCulture
– Rapid antigen detection testRapid antigen detection test
TreatmentTreatment
Pencillin V: 250mg BD given orally for 10 daysPencillin V: 250mg BD given orally for 10 days
Benzathine penicillin: 0.6 millon units for weight <27 kg (child)Benzathine penicillin: 0.6 millon units for weight <27 kg (child)
1.2 millon units intramuscularly (adult)1.2 millon units intramuscularly (adult)
as single doseas single dose
For pencillin allergic patient: erythromycin estolate 20-40mg/kg/dayFor pencillin allergic patient: erythromycin estolate 20-40mg/kg/day